Nordstrom to succeed Torre as McCann Healthcare chief executive

Share this article:
Richard Nordstrom has been named to succeed Joe Torre as global chief executive of McCann Healthcare Worldwide, a division of Interpublic Group's McCann Worldgroup. Torre will continue with McCann Healthcare Worldwide as chairman.
"I will be taking on a role focusing more on relationships and less on numbers," Torre said.
Nordstrom most recently was president of the New York office of Corbett Accel.
Scott Cotherman, chief executive of Corbett Accel, has stepped in as acting president of the New York office on an interim basis.
Nordstrom joined the Chicago-based Corbett Healthcare Group in 1998 as senior vice president, director of client services.
In early 2004, Omnicom divisions Corbett and Accel merged to form Corbett Accel. Accounts under Nordstrom's supervision there were Merck, Bristol-Myers Squibb, Sanofi-Synthelabo and Shire Pharmaceuticals.
Nordstrom is expected to begin his new role Jan. 3.
Share this article:
close

Next Article in News

Email Newsletters

More in News

Five things for pharma marketers to know: Thursday, August 21

Five things for pharma marketers to know: Thursday, ...

An Ebola survivor is set to leave Emory University Hospital, but the cause of the cure is uncertain, the FDA has approved a new type 1 diabetes test, and the ...

Sanofi expands Gaucher disease portfolio

Sanofi expands Gaucher disease portfolio

The oral medication Cerdelga joins Cerezyme in its Gaucher disease arsenal. Sanofi expects the drug will be priced "on par" with Cerezyme, which goes for around $300,000 a year in ...

Amicus seeks to upset Fabry market

Amicus seeks to upset Fabry market

Phase-III tests indicate patients may be able to switch from injectable enzyme-replacement therapies, like Fabrazyme, to the firm's oral drug.